TY - JOUR
T1 - Aspergillus meningitis
T2 - A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases
AU - Antinori, Spinello
AU - Corbellino, Mario
AU - Meroni, Luca
AU - Resta, Federico
AU - Sollima, Salvatore
AU - Tonolini, Massimo
AU - Tortorano, Anna Maria
AU - Milazzo, Laura
AU - Bello, Lorenzo
AU - Furfaro, Elisa
AU - Galli, Massimo
AU - Viscoli, Claudio
PY - 2013/3
Y1 - 2013/3
N2 - Objectives: To describe the pathogenesis, clinical presentation, cerebrospinal fluid findings and outcome of Aspergillus meningitis, meningoencephalitis and arachnoiditis. Methods: A case of Aspergillus meningitis is described. A comprehensive review of the English-language literature was conducted to identify all reported cases of Aspergillus meningitis described between January 1973 and December 2011. Results: Ninety-three cases (including the one described herein) of Aspergillus meningitis were identified. Fifty-two (55.9%) were in individuals without any predisposing factor or known causes of immunosuppression. Acute and chronic meningitis was diagnosed in 65.6% of patients and meningoencephalitis in 24.7% of them with the remaining presenting with spinal arachnoiditis and ventriculitis. Cerebrospinal fluid cultures for Aspergillus spp. were positive in about 31% of cases and the galactomannan antigen test in 87%. Diagnosis during life was achieved in 52 patients (55.9%) with a case fatality rate of 50%. The overall case fatality rate was 72.1%. Conclusions: Aspergillus meningitis may occur in both immunocompetent and immunocompromised patients and run an acute or chronic course. The findings of this systematic review extend the information on this life-threatening infection and could assist physicians in achieving an improved outcome.
AB - Objectives: To describe the pathogenesis, clinical presentation, cerebrospinal fluid findings and outcome of Aspergillus meningitis, meningoencephalitis and arachnoiditis. Methods: A case of Aspergillus meningitis is described. A comprehensive review of the English-language literature was conducted to identify all reported cases of Aspergillus meningitis described between January 1973 and December 2011. Results: Ninety-three cases (including the one described herein) of Aspergillus meningitis were identified. Fifty-two (55.9%) were in individuals without any predisposing factor or known causes of immunosuppression. Acute and chronic meningitis was diagnosed in 65.6% of patients and meningoencephalitis in 24.7% of them with the remaining presenting with spinal arachnoiditis and ventriculitis. Cerebrospinal fluid cultures for Aspergillus spp. were positive in about 31% of cases and the galactomannan antigen test in 87%. Diagnosis during life was achieved in 52 patients (55.9%) with a case fatality rate of 50%. The overall case fatality rate was 72.1%. Conclusions: Aspergillus meningitis may occur in both immunocompetent and immunocompromised patients and run an acute or chronic course. The findings of this systematic review extend the information on this life-threatening infection and could assist physicians in achieving an improved outcome.
KW - Aspergillus meningitis
KW - Diagnosis
KW - Galactomannan antigen
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=84873247383&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873247383&partnerID=8YFLogxK
U2 - 10.1016/j.jinf.2012.11.003
DO - 10.1016/j.jinf.2012.11.003
M3 - Article
C2 - 23178421
AN - SCOPUS:84873247383
VL - 66
SP - 218
EP - 238
JO - Journal of Infection
JF - Journal of Infection
SN - 0163-4453
IS - 3
ER -